December 8, 2023

CODA™ Anterior Cervical Plate System

Chung Chek Wong, Richard Bransford, Kazu Kitamura, Timothy Moore, Juan Zamorano, Nicolas Bronsard

CODA abstractfig
Fig 1: Two-level plate from the CODA™ Anterior Cervical Plate System. 

Anterior cervical discectomy and fusion (ACDF) is a common surgical procedure for treating cervical spine disorders such as degenerative disc disease, herniated discs, and cervical radiculopathy. The CODA™ Anterior Cervical Plate (ACP) System was developed to improve outcomes of anterior cervical fusion surgeries.

The CODA™ ACP System (Fig 1) includes low-profile titanium plates in various lengths (Fig 2 and Fig 3). The low profile is intended to reduce the incidence of dysphagia and other postoperative complications. The plates have bone grafting windows for better visibility during the surgical procedure and can accommodate variable angle and constrained angle screws with a double-lead screw thread. The combination of high screw angulation and the shorter 10 mm one-level plate could potentially reduce the incidence of adjacent vertebral-level degeneration and ossification. The plates have an integrated active locking mechanism that prevents screw loosening.

This innovative plating system potentially improves the efficiency of the surgical workflow by having one locking mechanism per level instead of one per screw. The instrumentation is streamlined, meaning that the same screwdriver can be used to insert the screw and deploy the locking mechanism. The threaded screwdriver included in the system (Fig 5b) secures the screw attachment and controls the screw during screw insertion [1].

Current clinical challenges in ACDF

Dysphagia
Dysphagia has long been recognized as a potential complication following ACDF [2, 3]. Despite its high incidence rate, the pathogenesis of this condition and associated risk factors are not well defined. A recent systematic literature review found a mean dysphagia rate of 19.4% following ACDF. Furthermore, zero-profile implants seemed to reduce dysphagia risk [2]. Therefore, the enhanced low-profile plate design of the CODA™ ACP System could offer as a key potential benefit a reduction in the incidence of dysphagia following ACDF procedures.

Adjacent segment degeneration
Although ACDF is clinically a highly successful procedure for disorders including cervical degenerative disc disease, adjacent segment degeneration (ASD) has been reported as a complication at the spinal level secondary to the rigid fixation. A recent study found that ASD occurred after single-level ACDF in 54% of cases, most commonly after C5/6 fusion (28%) [4]. The innovative design features of the CODA™ ACP System, including high screw angulation and shorter 10 mm one-level plate, may potentially reduce the occurrence of adjacent-level degeneration following ACDF.

Product details

The CODA™ ACP System consists of single-use titanium alloy (Ti-6Al-4V ELI) plates and screws that are available in both sterile and nonsterile sets. The plates are offered in various lengths and are low profile with a height of 1.9 mm (one- to three-level plates) and 2.1 mm (four- to five-level plates). The plates have bone grafting windows that allow optimal visualization of the graft, vertebral bodies, and endplates. The plates have an integrated active locking mechanism and can accommodate constrained angle and variable angle screws. The system includes nonsterile reusable instruments and sterile single-use instruments, designed to facilitate proper implantation of the plate and screws.

media-112976
Fig 2a–c: Two-level plate (a) oblique, (b) lateral, and (c) anterior views showing bone grafting windows, locking mechanism, and screws with double-lead screw thread.

Plates

The CODA™ ACP System plates are available in these lengths (Fig 3):

  • One level (lengths: 10–30 mm, increments of 2 mm)

  • Two levels (lengths: 24–44 mm, increments of 2 mm)

  • Three levels (lengths: 42–66 mm, increments of 3 mm)

  • Four levels (lengths: 60–88 mm, increments of 4 mm)

  • Five levels (lengths: 75–105 mm, increments of 5 mm)

The plate profile is 1.9 mm in 1–3-level plates, and 2.1 mm in 4–5-level plates. The screw locking mechanism is flush to the plate. The plate width is 17 mm at the widest point and 13 mm at the waist.

media-112968
Fig 3a-d: Single, two-, three-, and four-level plates.

Screws

The screws (Fig 4) are available as both sterile and nonsterile and feature a double-lead screw thread. Variable angle screws are available as self-drilling Ø3.5 mm screws (lengths: 10–18 mm), self-tapping Ø3.5 mm screws (lengths: 10–18, 20, and 22 mm) and self-tapping Ø4.0 mm screws (lengths: 12, 14, 16, and 18 mm). The plate screw holes permit a screw angulation of ±15° with cephalad/caudad range end holes from 2° to 32°.

Constrained angle screws are available as both self-tapping Ø3.5 mm screws (lengths: 10–18, 20, and 22 mm) and self-tapping Ø4.0 mm screws (lengths: 12, 14, 16, and 18 mm). 

media-112960
Fig 4a–b: (a) Variable- and constrained-angle screws from the CODA™ ACP System; (b) screw angulation permitted by the plate screw holes (±15° with cephalad/caudad range end holes from 2° to 32°).

Key features and benefits

Patients:

  • A low profile plate may potentially reduce incidence of dysphagia.

  • High screw angulation and shorter 10 mm one-level plate may potentially reduce occurrence of adjacent-level degeneration.

Surgeons/healthcare professionals:

  • Efficiency of surgical workflow is enhanced by having one locking mechanism per level instead of per screw. The positive stop on the locking mechanism is consistent for all plate levels.

  • The same T10 screwdriver can be used to insert screws and deploy the locking mechanism.

  • The threaded screwdriver provides secure attachment and control during screw insertion. 

Indications (United States only)

The CODA™ ACP System is intended for anterior fixation of the cervical spine (C2–7) as an adjunct to fusion in skeletally mature patients. Specific indications include degenerative disc disease (defined as neck pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies), spondylolisthesis, trauma (ie, fracture or dislocation), spinal stenosis, deformities or curvatures (ie, scoliosis, kyphosis, and/or lordosis), tumor, pseudarthrosis, and failed previous fusion.

Contraindications (United States only)

In adults, contraindications of the CODA™ ACP System and spinal fixation surgery include:

  • Active systemic infection or an infection localized to the site of the proposed implantation, including presence of fever

  • Severe osteoporosis which may prevent adequate fixation of screws and thus preclude the use of this or any other spinal instrumentation system

  • Patients who have been shown to be safely and predictably treated without internal fixation

  • Open wounds

  • Relative contraindications include any entity or condition that totally precludes the possibility of fusion (eg, cancer, kidney dialysis, or osteopenia), obesity, alcoholism or drug abuse, smoking, pregnancy, mental illness, certain degenerative diseases, and foreign body sensitivity.

References

  1. Resolve Surgical Technologies. Usability Test Report #2277, Revision 2, Jan 17, 2023.

  2. Tsalimas G, Evangelopoulos DS, Benetos IS, et al. Dysphagia as a Postoperative Complication of Anterior Cervical Discectomy and Fusion. Cureus. 2022 Jul 15;14(7): e26888.

  3. Carucci LR, Turner MA, Fitzhugh Yeatman C. Dysphagia Secondary to anterior cervical fusion: radiologic evaluation and findings in 74 patients. AJR Am J Roentgenol. 2015 Apr;204(4):768–775.

  4. Alhashash M, Shousha M, Boehm H. Adjacent Segment Disease After Cervical Spine Fusion: Evaluation of a 70 Patient Long-Term Follow-Up. Spine. 2018 May 1;43(9):605–609.

“approved by AO Technical Commission” and “approved by AO Foundation”
The brands and labels “approved by AO Technical Commission” and “approved by AO Foundation”, particularly "AO" and the AO logo, are AO Foundation's intellectual property and subject to trademark applications and registrations, respectively. The use of these brands and labels is regulated by licensing agreements between AO Foundation and the producers of innovation products obliged to use such labels to declare the products as AO Technical Commission or AO Foundation approved solutions. Any unauthorized or inadequate use of these trademarks may be subject to legal action.